 Keith Neeves
Concepts (355)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 27 | 2022 | 350 | 5.410 |
Why?
| | Microfluidic Analytical Techniques | 19 | 2018 | 72 | 4.120 |
Why?
| | Thrombosis | 20 | 2023 | 302 | 4.010 |
Why?
| | Blood Coagulation | 20 | 2021 | 221 | 3.680 |
Why?
| | Fibrin | 9 | 2018 | 65 | 2.440 |
Why?
| | Hemostasis | 8 | 2021 | 67 | 2.390 |
Why?
| | Platelet Aggregation | 14 | 2022 | 94 | 2.080 |
Why?
| | Platelet Activation | 7 | 2023 | 68 | 1.570 |
Why?
| | Thrombin | 5 | 2020 | 141 | 1.520 |
Why?
| | Colloids | 4 | 2020 | 57 | 1.490 |
Why?
| | Hemophilia A | 4 | 2023 | 70 | 1.450 |
Why?
| | Fibrinolysis | 4 | 2021 | 160 | 1.430 |
Why?
| | Drug Delivery Systems | 6 | 2022 | 301 | 1.420 |
Why?
| | Microfluidics | 10 | 2020 | 50 | 1.320 |
Why?
| | Tissue Plasminogen Activator | 2 | 2021 | 228 | 1.190 |
Why?
| | Platelet Adhesiveness | 6 | 2019 | 15 | 1.170 |
Why?
| | Vascular System Injuries | 3 | 2017 | 65 | 1.070 |
Why?
| | Lab-On-A-Chip Devices | 5 | 2021 | 35 | 1.030 |
Why?
| | Collagen | 9 | 2019 | 415 | 1.000 |
Why?
| | Blood Platelet Disorders | 2 | 2023 | 10 | 0.950 |
Why?
| | Magnetic Fields | 5 | 2022 | 22 | 0.910 |
Why?
| | Nanoparticles | 4 | 2019 | 318 | 0.900 |
Why?
| | Biomimetics | 2 | 2014 | 36 | 0.900 |
Why?
| | von Willebrand Factor | 5 | 2019 | 56 | 0.880 |
Why?
| | Erythrocytes | 3 | 2018 | 590 | 0.810 |
Why?
| | Plasminogen | 1 | 2021 | 32 | 0.790 |
Why?
| | Nanomedicine | 2 | 2022 | 28 | 0.730 |
Why?
| | Platelet Membrane Glycoproteins | 3 | 2018 | 37 | 0.720 |
Why?
| | Rheology | 3 | 2016 | 88 | 0.700 |
Why?
| | Plasminogen Activators | 1 | 2019 | 7 | 0.700 |
Why?
| | Thromboplastin | 7 | 2018 | 71 | 0.700 |
Why?
| | Models, Biological | 7 | 2020 | 1647 | 0.690 |
Why?
| | Fibrinolysin | 1 | 2019 | 15 | 0.690 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 76 | 0.680 |
Why?
| | Tranexamic Acid | 1 | 2019 | 40 | 0.650 |
Why?
| | Antifibrinolytic Agents | 1 | 2019 | 50 | 0.650 |
Why?
| | Thrombolytic Therapy | 1 | 2019 | 118 | 0.640 |
Why?
| | Drug Carriers | 1 | 2019 | 113 | 0.640 |
Why?
| | Regional Blood Flow | 4 | 2017 | 414 | 0.640 |
Why?
| | Venous Valves | 1 | 2018 | 1 | 0.620 |
Why?
| | Cesium | 1 | 2018 | 17 | 0.620 |
Why?
| | Fibrinogen | 3 | 2017 | 160 | 0.580 |
Why?
| | Fibrinolytic Agents | 1 | 2019 | 233 | 0.570 |
Why?
| | Genetic Diseases, Inborn | 1 | 2017 | 37 | 0.570 |
Why?
| | Torpor | 1 | 2017 | 14 | 0.570 |
Why?
| | Hemorrhage | 2 | 2019 | 616 | 0.560 |
Why?
| | Venous Thrombosis | 1 | 2018 | 147 | 0.540 |
Why?
| | Pharmaceutical Preparations | 3 | 2021 | 169 | 0.520 |
Why?
| | Sciuridae | 1 | 2017 | 142 | 0.510 |
Why?
| | Heating | 1 | 2015 | 18 | 0.510 |
Why?
| | Water Pollutants, Chemical | 1 | 2018 | 174 | 0.510 |
Why?
| | Ferric Compounds | 1 | 2015 | 40 | 0.500 |
Why?
| | Bleeding Time | 1 | 2015 | 6 | 0.500 |
Why?
| | Protein Aggregates | 1 | 2015 | 66 | 0.490 |
Why?
| | Chlorides | 1 | 2015 | 130 | 0.490 |
Why?
| | Humans | 50 | 2023 | 115908 | 0.490 |
Why?
| | Saphenous Vein | 1 | 2015 | 31 | 0.490 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2018 | 20 | 0.480 |
Why?
| | Cell Adhesion | 3 | 2014 | 433 | 0.480 |
Why?
| | Stress, Mechanical | 7 | 2018 | 440 | 0.470 |
Why?
| | Animals | 32 | 2022 | 32123 | 0.430 |
Why?
| | Epigastric Arteries | 1 | 2012 | 18 | 0.430 |
Why?
| | Polymers | 4 | 2015 | 464 | 0.430 |
Why?
| | Femoral Vein | 1 | 2012 | 28 | 0.420 |
Why?
| | Collagen Type I | 1 | 2013 | 110 | 0.410 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 72 | 0.410 |
Why?
| | Extracellular Fluid | 2 | 2013 | 31 | 0.410 |
Why?
| | E-Selectin | 1 | 2012 | 53 | 0.400 |
Why?
| | Nanotubes | 1 | 2012 | 41 | 0.390 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2012 | 59 | 0.390 |
Why?
| | Carotid Arteries | 1 | 2012 | 183 | 0.380 |
Why?
| | Fibrin Clot Lysis Time | 2 | 2021 | 8 | 0.380 |
Why?
| | Cell Separation | 1 | 2012 | 293 | 0.370 |
Why?
| | Hemodynamics | 4 | 2018 | 970 | 0.370 |
Why?
| | Vascular Diseases | 1 | 2013 | 230 | 0.370 |
Why?
| | Factor V | 2 | 2020 | 22 | 0.360 |
Why?
| | Endothelial Cells | 1 | 2015 | 694 | 0.350 |
Why?
| | Biophysics | 1 | 2010 | 70 | 0.340 |
Why?
| | Blood Flow Velocity | 4 | 2018 | 324 | 0.340 |
Why?
| | Factor VIII | 3 | 2020 | 54 | 0.330 |
Why?
| | Groundwater | 2 | 2020 | 33 | 0.330 |
Why?
| | Receptors, Thrombin | 1 | 2008 | 11 | 0.320 |
Why?
| | Kinetics | 5 | 2018 | 1560 | 0.310 |
Why?
| | Platelet Function Tests | 3 | 2021 | 24 | 0.310 |
Why?
| | Pulmonary Embolism | 2 | 2022 | 182 | 0.310 |
Why?
| | Adenosine Diphosphate | 1 | 2008 | 81 | 0.300 |
Why?
| | Nitric Oxide | 1 | 2013 | 834 | 0.300 |
Why?
| | Membranes, Artificial | 1 | 2008 | 67 | 0.300 |
Why?
| | Porosity | 3 | 2020 | 93 | 0.300 |
Why?
| | Neostriatum | 1 | 2007 | 29 | 0.300 |
Why?
| | Dilatation | 1 | 2007 | 59 | 0.290 |
Why?
| | Computer Simulation | 3 | 2020 | 887 | 0.290 |
Why?
| | Biological Transport | 3 | 2017 | 373 | 0.260 |
Why?
| | Silicon Dioxide | 2 | 2018 | 94 | 0.250 |
Why?
| | Extracellular Matrix | 2 | 2011 | 439 | 0.250 |
Why?
| | Hydrodynamics | 5 | 2019 | 34 | 0.240 |
Why?
| | Equipment Design | 6 | 2016 | 516 | 0.240 |
Why?
| | Microscopy, Electron, Scanning | 3 | 2014 | 194 | 0.220 |
Why?
| | von Willebrand Diseases | 1 | 2023 | 11 | 0.220 |
Why?
| | Shear Strength | 4 | 2019 | 55 | 0.210 |
Why?
| | Gels | 2 | 2015 | 72 | 0.210 |
Why?
| | Leukocyte Elastase | 1 | 2022 | 79 | 0.200 |
Why?
| | Metabolic Flux Analysis | 1 | 2021 | 7 | 0.200 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2022 | 79 | 0.200 |
Why?
| | Models, Cardiovascular | 2 | 2016 | 172 | 0.190 |
Why?
| | Respiratory Mucosa | 2 | 2014 | 261 | 0.190 |
Why?
| | Hematocrit | 2 | 2018 | 86 | 0.190 |
Why?
| | Models, Theoretical | 3 | 2019 | 527 | 0.180 |
Why?
| | Mice | 13 | 2022 | 15075 | 0.180 |
Why?
| | Blood Coagulation Tests | 2 | 2021 | 57 | 0.170 |
Why?
| | High-Energy Shock Waves | 1 | 2019 | 4 | 0.170 |
Why?
| | Semaphorins | 2 | 2010 | 21 | 0.170 |
Why?
| | ADAMTS13 Protein | 1 | 2019 | 4 | 0.170 |
Why?
| | Magnetite Nanoparticles | 1 | 2019 | 28 | 0.170 |
Why?
| | Convection | 3 | 2011 | 7 | 0.170 |
Why?
| | Male | 18 | 2023 | 56128 | 0.170 |
Why?
| | Drug Compounding | 1 | 2019 | 89 | 0.170 |
Why?
| | Herpes Zoster | 1 | 2023 | 333 | 0.160 |
Why?
| | Microelectrodes | 3 | 2007 | 32 | 0.160 |
Why?
| | Liposomes | 1 | 2019 | 149 | 0.160 |
Why?
| | Robotics | 1 | 2019 | 79 | 0.160 |
Why?
| | Geologic Sediments | 1 | 2018 | 35 | 0.150 |
Why?
| | von Willebrand Disease, Type 1 | 1 | 2017 | 1 | 0.150 |
Why?
| | Hemorheology | 1 | 2017 | 20 | 0.150 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2018 | 43 | 0.150 |
Why?
| | Phosphatidylserines | 1 | 2018 | 87 | 0.150 |
Why?
| | Viscosity | 2 | 2015 | 82 | 0.150 |
Why?
| | Flow Cytometry | 3 | 2016 | 1059 | 0.150 |
Why?
| | Antigens, CD | 2 | 2010 | 443 | 0.150 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 177 | 0.150 |
Why?
| | Antithrombin III | 1 | 2017 | 7 | 0.150 |
Why?
| | MAP Kinase Kinase Kinase 5 | 1 | 2016 | 3 | 0.140 |
Why?
| | Magnetics | 1 | 2017 | 38 | 0.140 |
Why?
| | Thromboxane A2 | 1 | 2016 | 12 | 0.140 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2018 | 399 | 0.140 |
Why?
| | Adsorption | 2 | 2020 | 127 | 0.140 |
Why?
| | Peptide Hydrolases | 1 | 2017 | 109 | 0.130 |
Why?
| | Adenine | 1 | 2018 | 221 | 0.130 |
Why?
| | Models, Molecular | 1 | 2021 | 1392 | 0.130 |
Why?
| | Blood Cells | 1 | 2015 | 39 | 0.130 |
Why?
| | Piperazines | 1 | 2018 | 313 | 0.130 |
Why?
| | Models, Anatomic | 1 | 2016 | 92 | 0.130 |
Why?
| | Time Factors | 4 | 2017 | 6186 | 0.130 |
Why?
| | Pneumonia | 1 | 2020 | 576 | 0.130 |
Why?
| | Clot Retraction | 1 | 2015 | 1 | 0.130 |
Why?
| | Electrodes | 1 | 2015 | 99 | 0.120 |
Why?
| | Arteries | 1 | 2017 | 249 | 0.120 |
Why?
| | Stroke | 1 | 2023 | 1014 | 0.120 |
Why?
| | Signal Transduction | 4 | 2018 | 4526 | 0.120 |
Why?
| | Hypoxia | 1 | 2020 | 937 | 0.120 |
Why?
| | Elastic Modulus | 1 | 2015 | 118 | 0.120 |
Why?
| | Bioreactors | 1 | 2014 | 45 | 0.120 |
Why?
| | Temperature | 1 | 2017 | 590 | 0.120 |
Why?
| | Blood Vessels | 1 | 2016 | 181 | 0.120 |
Why?
| | Toxicity Tests | 1 | 2014 | 27 | 0.120 |
Why?
| | Rats | 5 | 2014 | 5035 | 0.120 |
Why?
| | Enzyme Precursors | 1 | 2014 | 15 | 0.120 |
Why?
| | Nanotechnology | 2 | 2013 | 115 | 0.120 |
Why?
| | Rats, Sprague-Dawley | 3 | 2011 | 2262 | 0.110 |
Why?
| | Factor VIIa | 1 | 2013 | 36 | 0.110 |
Why?
| | Microscopy, Confocal | 1 | 2015 | 298 | 0.110 |
Why?
| | Cysteine Endopeptidases | 1 | 2013 | 61 | 0.110 |
Why?
| | Bronchi | 2 | 2012 | 253 | 0.110 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2014 | 82 | 0.110 |
Why?
| | Azo Compounds | 1 | 2013 | 25 | 0.110 |
Why?
| | Optical Tweezers | 1 | 2013 | 20 | 0.110 |
Why?
| | Models, Chemical | 1 | 2015 | 264 | 0.110 |
Why?
| | International Cooperation | 1 | 2014 | 175 | 0.110 |
Why?
| | Surface Properties | 2 | 2019 | 397 | 0.110 |
Why?
| | Materials Testing | 1 | 2015 | 357 | 0.110 |
Why?
| | Receptor, PAR-2 | 1 | 2012 | 8 | 0.110 |
Why?
| | Biomechanical Phenomena | 2 | 2013 | 678 | 0.110 |
Why?
| | Disease Models, Animal | 4 | 2020 | 3582 | 0.110 |
Why?
| | Fibrillar Collagens | 1 | 2012 | 12 | 0.110 |
Why?
| | Lipid Bilayers | 1 | 2014 | 100 | 0.110 |
Why?
| | Permeability | 1 | 2013 | 151 | 0.110 |
Why?
| | Factor VII | 1 | 2012 | 26 | 0.110 |
Why?
| | Receptor, PAR-1 | 1 | 2012 | 21 | 0.110 |
Why?
| | Horses | 1 | 2013 | 97 | 0.110 |
Why?
| | Spectrophotometry | 1 | 2012 | 48 | 0.100 |
Why?
| | Polymerization | 1 | 2013 | 119 | 0.100 |
Why?
| | Cells, Cultured | 3 | 2015 | 3916 | 0.100 |
Why?
| | Microvilli | 1 | 2012 | 70 | 0.100 |
Why?
| | Linear Models | 1 | 2015 | 778 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 789 | 0.100 |
Why?
| | Observer Variation | 1 | 2013 | 299 | 0.100 |
Why?
| | Microscopy, Fluorescence | 1 | 2014 | 403 | 0.100 |
Why?
| | Cell Culture Techniques | 1 | 2014 | 346 | 0.100 |
Why?
| | Polystyrenes | 2 | 2011 | 35 | 0.100 |
Why?
| | Protein Binding | 2 | 2020 | 1919 | 0.100 |
Why?
| | Surface Plasmon Resonance | 1 | 2011 | 82 | 0.100 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2011 | 66 | 0.100 |
Why?
| | Female | 10 | 2023 | 60086 | 0.100 |
Why?
| | Lung | 2 | 2020 | 3685 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2014 | 965 | 0.090 |
Why?
| | Blood Coagulation Disorders | 1 | 2013 | 196 | 0.090 |
Why?
| | Microscopy, Atomic Force | 1 | 2011 | 116 | 0.090 |
Why?
| | Cell Membrane | 2 | 2015 | 682 | 0.090 |
Why?
| | Platelet Factor 4 | 2 | 2020 | 21 | 0.090 |
Why?
| | Ozone | 1 | 2011 | 105 | 0.090 |
Why?
| | Neoplasm Proteins | 1 | 2013 | 388 | 0.090 |
Why?
| | Integrins | 1 | 2010 | 79 | 0.090 |
Why?
| | Myocytes, Cardiac | 1 | 2014 | 456 | 0.090 |
Why?
| | Societies, Medical | 1 | 2014 | 690 | 0.090 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 694 | 0.080 |
Why?
| | Absorbable Implants | 1 | 2009 | 35 | 0.080 |
Why?
| | Brain Diseases | 1 | 2010 | 127 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2016 | 2814 | 0.080 |
Why?
| | src-Family Kinases | 1 | 2009 | 87 | 0.080 |
Why?
| | Integrin alpha2beta1 | 1 | 2008 | 3 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2020 | 1752 | 0.080 |
Why?
| | Water | 1 | 2011 | 418 | 0.080 |
Why?
| | Dimethylpolysiloxanes | 1 | 2008 | 9 | 0.080 |
Why?
| | Cerebral Cortex | 1 | 2011 | 390 | 0.080 |
Why?
| | Hyperlipidemias | 1 | 2009 | 123 | 0.080 |
Why?
| | Silicones | 1 | 2008 | 21 | 0.080 |
Why?
| | Cell Membrane Permeability | 1 | 2008 | 83 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 389 | 0.080 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2007 | 8 | 0.080 |
Why?
| | Protein Array Analysis | 1 | 2008 | 61 | 0.070 |
Why?
| | Electrodes, Implanted | 2 | 2006 | 93 | 0.070 |
Why?
| | Osmolar Concentration | 1 | 2007 | 178 | 0.070 |
Why?
| | Molecular Weight | 1 | 2007 | 335 | 0.070 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2010 | 394 | 0.070 |
Why?
| | Tissue Distribution | 1 | 2007 | 324 | 0.070 |
Why?
| | Algorithms | 2 | 2011 | 1494 | 0.070 |
Why?
| | Reference Values | 1 | 2008 | 745 | 0.070 |
Why?
| | Insecta | 1 | 2006 | 63 | 0.070 |
Why?
| | Evans Blue | 1 | 2006 | 6 | 0.070 |
Why?
| | Caudate Nucleus | 1 | 2006 | 14 | 0.070 |
Why?
| | Phenotype | 1 | 2013 | 2861 | 0.070 |
Why?
| | Diffusion | 1 | 2006 | 120 | 0.060 |
Why?
| | Extremities | 1 | 2006 | 113 | 0.060 |
Why?
| | Brain | 2 | 2009 | 2382 | 0.060 |
Why?
| | Albumins | 1 | 2006 | 91 | 0.060 |
Why?
| | Atherosclerosis | 1 | 2009 | 339 | 0.060 |
Why?
| | Muscles | 1 | 2006 | 328 | 0.060 |
Why?
| | Infusions, Intravenous | 1 | 2006 | 374 | 0.060 |
Why?
| | Infusion Pumps, Implantable | 1 | 2004 | 20 | 0.060 |
Why?
| | Foreign-Body Reaction | 1 | 2004 | 23 | 0.060 |
Why?
| | Anticoagulants | 2 | 2021 | 545 | 0.060 |
Why?
| | Movement | 2 | 2017 | 246 | 0.060 |
Why?
| | Child, Preschool | 2 | 2017 | 9175 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1728 | 0.060 |
Why?
| | Immunoblotting | 2 | 2016 | 283 | 0.060 |
Why?
| | Elasticity | 2 | 2015 | 194 | 0.060 |
Why?
| | Electric Impedance | 2 | 2014 | 99 | 0.050 |
Why?
| | Brain Neoplasms | 1 | 2010 | 979 | 0.050 |
Why?
| | P-Selectin | 1 | 2022 | 26 | 0.050 |
Why?
| | Young Adult | 2 | 2017 | 10518 | 0.050 |
Why?
| | Apolipoprotein A-I | 1 | 2022 | 25 | 0.050 |
Why?
| | CD36 Antigens | 1 | 2022 | 38 | 0.050 |
Why?
| | Cystic Fibrosis | 1 | 2011 | 961 | 0.050 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 55 | 0.050 |
Why?
| | Mice, Knockout | 3 | 2016 | 2606 | 0.050 |
Why?
| | Arachidonic Acid | 1 | 2022 | 118 | 0.050 |
Why?
| | Exosomes | 1 | 2023 | 92 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 46 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 4769 | 0.050 |
Why?
| | Blood Pressure | 1 | 2008 | 1536 | 0.050 |
Why?
| | Blood Specimen Collection | 1 | 2021 | 32 | 0.050 |
Why?
| | Plasma | 1 | 2023 | 213 | 0.050 |
Why?
| | Chemokine CCL5 | 1 | 2020 | 48 | 0.050 |
Why?
| | Factor Xa | 1 | 2020 | 32 | 0.050 |
Why?
| | Carbon | 1 | 2021 | 164 | 0.050 |
Why?
| | Glycolysis | 1 | 2021 | 222 | 0.050 |
Why?
| | Binding, Competitive | 1 | 2020 | 200 | 0.050 |
Why?
| | Phosphorylation | 2 | 2018 | 1561 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2020 | 100 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 139 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2022 | 399 | 0.040 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2020 | 19 | 0.040 |
Why?
| | Research | 1 | 2023 | 398 | 0.040 |
Why?
| | Adolescent | 2 | 2017 | 17955 | 0.040 |
Why?
| | Adult | 3 | 2019 | 30820 | 0.040 |
Why?
| | Catheterization | 2 | 2010 | 160 | 0.040 |
Why?
| | Herpesvirus 3, Human | 1 | 2023 | 381 | 0.040 |
Why?
| | Rotation | 1 | 2019 | 113 | 0.040 |
Why?
| | Motion | 1 | 2019 | 94 | 0.040 |
Why?
| | Thrombocytopenia | 1 | 2020 | 175 | 0.040 |
Why?
| | Bleomycin | 1 | 2020 | 232 | 0.040 |
Why?
| | Deamino Arginine Vasopressin | 1 | 2017 | 10 | 0.040 |
Why?
| | Serotonin | 1 | 2020 | 296 | 0.040 |
Why?
| | Uncertainty | 1 | 2018 | 98 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2020 | 780 | 0.040 |
Why?
| | Purinergic P2Y Receptor Antagonists | 1 | 2018 | 62 | 0.040 |
Why?
| | Hemostatics | 1 | 2017 | 48 | 0.040 |
Why?
| | Drug Synergism | 1 | 2018 | 316 | 0.040 |
Why?
| | Machine Learning | 1 | 2020 | 319 | 0.040 |
Why?
| | Neutrophils | 1 | 2022 | 1170 | 0.040 |
Why?
| | Cytoplasmic Granules | 1 | 2016 | 82 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 351 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2018 | 225 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 605 | 0.030 |
Why?
| | Miniaturization | 1 | 2015 | 24 | 0.030 |
Why?
| | Blood Circulation | 1 | 2015 | 35 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2018 | 961 | 0.030 |
Why?
| | Thrombopoiesis | 1 | 2014 | 6 | 0.030 |
Why?
| | Nanostructures | 1 | 2016 | 98 | 0.030 |
Why?
| | Megakaryocytes | 1 | 2014 | 30 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 609 | 0.030 |
Why?
| | Platelet Transfusion | 1 | 2014 | 63 | 0.030 |
Why?
| | Chlorine | 1 | 2014 | 62 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2015 | 184 | 0.030 |
Why?
| | Risk Assessment | 1 | 2023 | 3004 | 0.030 |
Why?
| | Biomimetic Materials | 1 | 2014 | 64 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1359 | 0.030 |
Why?
| | Inhalation Exposure | 1 | 2014 | 103 | 0.030 |
Why?
| | Erythrocyte Deformability | 1 | 2013 | 12 | 0.030 |
Why?
| | Gases | 1 | 2013 | 42 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1817 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2014 | 647 | 0.030 |
Why?
| | Pressure | 1 | 2013 | 218 | 0.030 |
Why?
| | Nitrogen | 1 | 2013 | 150 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 304 | 0.020 |
Why?
| | Serum Albumin, Bovine | 1 | 2011 | 65 | 0.020 |
Why?
| | Cell Death | 1 | 2012 | 324 | 0.020 |
Why?
| | Microtechnology | 1 | 2010 | 5 | 0.020 |
Why?
| | Syk Kinase | 1 | 2010 | 16 | 0.020 |
Why?
| | Phospholipase C gamma | 1 | 2010 | 25 | 0.020 |
Why?
| | Trachea | 1 | 2012 | 234 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2017 | 3054 | 0.020 |
Why?
| | Molecular Dynamics Simulation | 1 | 2012 | 209 | 0.020 |
Why?
| | Catheters | 1 | 2010 | 64 | 0.020 |
Why?
| | Particle Size | 1 | 2011 | 341 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2012 | 546 | 0.020 |
Why?
| | Wound Healing | 1 | 2012 | 263 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2010 | 154 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2503 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2011 | 302 | 0.020 |
Why?
| | Polyglactin 910 | 1 | 2009 | 10 | 0.020 |
Why?
| | Diet, Atherogenic | 1 | 2009 | 7 | 0.020 |
Why?
| | Proline | 1 | 2009 | 72 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1026 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 27084 | 0.020 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2011 | 288 | 0.020 |
Why?
| | Factor XIIa | 1 | 2008 | 1 | 0.020 |
Why?
| | Platelet Glycoprotein GPIb-IX Complex | 1 | 2008 | 3 | 0.020 |
Why?
| | Plant Proteins | 1 | 2008 | 80 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 3474 | 0.020 |
Why?
| | Amplifiers, Electronic | 1 | 2006 | 9 | 0.020 |
Why?
| | Xylenes | 1 | 2006 | 7 | 0.020 |
Why?
| | Cockroaches | 1 | 2006 | 22 | 0.020 |
Why?
| | Aorta, Thoracic | 1 | 2009 | 250 | 0.020 |
Why?
| | Electrophysiology | 1 | 2006 | 202 | 0.020 |
Why?
| | Locomotion | 1 | 2006 | 81 | 0.020 |
Why?
| | Transferrin | 1 | 2004 | 40 | 0.020 |
Why?
| | Calcium | 1 | 2010 | 1102 | 0.020 |
Why?
| | Equipment Failure | 1 | 2004 | 109 | 0.010 |
Why?
| | Running | 1 | 2006 | 209 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2017 | 9166 | 0.010 |
Why?
| | Cytokines | 1 | 2011 | 1857 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2004 | 750 | 0.010 |
Why?
| | Aged | 1 | 2017 | 19299 | 0.010 |
Why?
| | Child | 1 | 2017 | 18555 | 0.010 |
Why?
|
|
Neeves's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|